Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Acetamide, N-(((((4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl)(((4-(trifluoromethyl)phenyl)sulfonyl)amino)methylene)amino)iminomethyl)-

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corbus Pharmaceuticals Starts Phase 1 Study of CRB-913 for Obesity
    Corbus Pharmaceuticals Starts Phase 1 Study of CRB-913 for Obesity

    28 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/28/3051321/0/en/Corbus-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Study-of-Next-Generation-CB1-Inverse-Agonist-CRB-913-for-the-Treatment-of-Obesity.html

    GLOBENEWSWIRE
    28 Mar 2025
    Share Share
    Novo fails trial, linking obesity asset to psychiatric effects
    Novo fails trial, linking obesity asset to psychiatric effects

    06 Feb 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/novo-flunks-kidney-disease-trial-again-linking-obesity-prospect-neuropsychiatric-side

    FIERCE BIOTECH
    06 Feb 2025
    Share Share
    Corbus Pharma Presents CRB-913 Data at ObesityWeek® 2024
    Corbus Pharma Presents CRB-913 Data at ObesityWeek® 2024

    04 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/04/2973892/0/en/Corbus-Pharmaceuticals-Presents-New-CRB-913-Pre-Clinical-Data-At-Obesity-Week-2024.html

    GLOBENEWSWIRE
    04 Nov 2024
    Share Share